In the lead up to International Women’s Day 2026, women’s health leaders, experts and insiders explore the critical challenges shaping the future of women’s health

For generations, women’s health was relegated to the margins of medical research, funding, and systems design. Today, it is becoming a market force.

Recent research shows women’s health investment topped US$2.6 billion in 2024 — a 55 per cent year-over-year increase. 

If you expand the category to include the myriad health issues known to disproportionately affect women, we are looking at $10.7 billion in investment, as numbers continue to rise.

Women are finally being seen. This is fantastic! But it’s not everything.

Despite all of the positive data, women still navigate fragmented care pathways, receive delayed diagnoses, and face inconsistent outcomes across every life stage. Why?

It’s not a lack of passion or innovation or even investment dollars. It’s a lack of infrastructure.

We have been building around the system when we need to be building within it.

What “Infrastructure” Really Means in Women’s Health

When I talk about infrastructure, I mean the creation of a foundational layer that makes coordinated, longitudinal care possible.

It is vitally important that providers have all of the data they need regarding a patient’s health, following their story from a woman’s first OB/GYN visit all the way through menopause and beyond.

So, in terms of infrastructure, I’m referring to the tools that make this possible — interoperable EHR systems, AI that reduces documentation burdens, integrated clinical workflows, and billing models that support preventive and reproductive care.

This level of integration and coordination has been missing for far too long.

Lots of options are entering the market to address pieces of the puzzle, but when shiny new tools are introduced, however well-intentioned and well-designed, they typically require additional logins, more toggling between systems, and redundant manual entry.

While potentially solving one problem, technology all too often creates others.

The sad fact is that innovation that causes more friction won’t scale, no matter how good the tech is or how much potential it holds.

The Real Cost of Fragmentation

Consider a woman with gestational diabetes during her pregnancy. This fact is part of her chart, but the chart lives with her OB.

Years later, this patient will be at higher risk for Type 2 diabetes, but her primary care provider may never have any idea.

This doesn’t happen out of a lack of caring but rather because systems between practices can’t talk to each other.

This failure to communicate and synthesize information can lead to misdiagnoses, unnecessary tests or medications, and delayed care.

Pregnancy complications are among the strongest early indicators of issues beyond diabetes; they can also predict things like future cardiovascular risk.

And to this point, pregnancy data almost never informs the longitudinal cardiovascular risk models that follow a woman through her life.

The persistent fragmentation issue also increases the cognitive load for clinicians who try to reconcile patient data across platforms.

They have to piecemeal everything together to get a complete picture of a patient, and doing a comprehensive job for every patient, day-in and day-out, is simply not feasible.

Advocating for their own care, then, often falls upon female patients themselves, who have long had their symptoms discounted or brushed aside.

This is not fair to anyone, but it has been our reality.

Point Solutions Alone Are Not Enough

I have profound respect for the founders building point solutions in women’s health.

Many are doing deeply important work that addresses long-neglected needs. This work is necessary and it matters.

For these solutions to achieve durable, system-wide impact, however, they must connect to the broader care delivery environment.

Clinical adoption depends on interoperability; sustainability depends on reimbursement alignment; meaningful outcomes depend on whether insights can travel with patients across providers and time.

And so on.

So how do we support modern solutions with the connective tissue necessary to scale? Building connective tissue is a shared responsibility — and a shared opportunity.

What Scalable Women’s Health Innovation Requires

As we press forward to define a better future for women’s health, it is paramount that we create longitudinal data architecture.

Think of how powerful it could be if reproductive, metabolic, cardiovascular, mental health and other domains were all connected through an integrated record that moved with a patient throughout her life, picking up all the signals from each clinically rich chapter of a single, continuous health story.

This should be a given, but we’re not there yet.

Next, we need AI embedded into the workflow, not layered on top of it.

AI will be indispensable in terms of proactively spotting issues, tracking indicators, surfacing information, and making sense of the millions of data points providers collect on patients throughout their lives — which can then be used to aid in physician decision-making.

AI can also provide a much-needed assist in supporting documentation.

By using AI for the things machines do well, we can free clinicians to do what only humans can, but it has to sit at the core not on the fringe.

We also have to have policy and reimbursement alignment. Innovation can’t continue to outpace payment models indefinitely.

Maternal health equity and preventive care need structural support as funded clinical priorities.

If we want providers to adopt and sustain women’s health solutions, the reimbursement framework has to make it viable.

And finally, we need privacy and governance rooted in trust. In reproductive health, in particular, this is absolutely vital.

For patients to feel comfortable sharing their data and engaging in a longitudinal, connected care model, they must be confident their information is secure and that they are protected.

Women are in an incredibly vulnerable position.

As such, data governance can’t be solely a compliance checkbox. It’s an ethical commitment.

The next wave of women’s health innovation won’t be defined by a single company or product.

It will be decided by whether we can build the infrastructure layer that allows those products to work together for everyone’s benefit.

If we are successful, we will positively shape the foundation of care for generations to come.

As first seen on Femtech World: https://www.femtechworld.co.uk/international-womens-day-2026/womens-health-innovation-needs-infrastructure-not-just-investment-mens26/